Contact
Please use this form to send email to PR contact of this press release:
Halozyme Therapeutics Sells 6.15 Million Common Shares
TO:
Please use this form to send email to PR contact of this press release:
Halozyme Therapeutics Sells 6.15 Million Common Shares
TO: